1640 (M.A. Bioproducts, Walkersville, MD) without FCS were treated with anti-AGM, at a final dilution of 1 :100, anti-Thy-I (1 :10), anti-Ly-1 .1 (1 :20) , or anti-Ly-2.1 (1 :20) plus complement (1 :10) for 1 h at 37°C; cells were washed twice after treatment . YAC-1 cells, originally derived from a Moloney virus-induced lymphoma in an A/Sn mouse and used widely to assay cytotoxicity of murine NK cells (6) were grown continuously.
Hepatic NPC Isolation. Under sterile conditions, NPC were purified as previously described (7) by collagenase perfusion of the portal vein and Metrizamide density centrifugation . Total recovery ranged from 2-8 X 106 NPC per liver. Contamination by hepatocytes, as determined by counting 200 cells from the preparation, was <1% . In selected experiments the NPC were adhered to 100-mm Petri dish (No. 3003 ; Falcon Labware, Oxnard, CA) for 90 min at 37°C (5% C02, 100% humidity) or treated with carbonyl iron particles by mixing 107 NPCs in 10 ml RPMI 1640 plus 5% FCS with 100 mg of carbonyl iron particles . The mixture was poured into 100-mm Petri dish. After incubation for 1 h at 37°C, the carbonyl iron particles were moved to one side of the dish with the magnet ; and the nonadherent cells were then washed twice with fresh medium .
Spleen Cells and Peripheral Blood Leukocytes (PBL). Spleen cell suspensions were prepared by gently pressing spleen through a 150-mesh stainless steel sieve into RPMI 1640 plus 10% FCS followed by gravity sedimentation . PBL were obtained by phlebotomy of the retro-orbital plexus. Spleen cells and PBL were each separated on Ficoll-Hypaque gradients, washed twice, and resuspended in RPMI 1640 plus 10% FCS .
Assayfor NK Activity . YAC-1 target cells (106/100 Al) were labeled with 100 ACi 5 'Cr (New England Nuclear, Boston, MA) during 1 h of incubation at 37°C in 5% C02. After incubation the labeled YAC-I cells were washed three times and resuspended in RPMI 1640 medium with 10% FCS . NPC in 100 Pl RPMI plus 10% FCS were serially diluted in V-bottomed 96-well microtiter trays (Dynatech Laboratories, Inc ., Alexandria, VA) and mixed with 5 X 10' 5' Cr-labeled YAC-I cells in 100 j.l medium . Plates were spun at 650g for 3 min. After a 4-h incubation at 37°C, 100 jl ofeach supernatant were measured for radioactivity with a gamma counter . The percent lysis was calculated using the following formula : specific lysis = 100 X [(experimental release -spontaneous release)/(maximum release -spontaneous release)] . Spontaneous release was always <15% of the maximum release . Maximum release was calculated by mixing 50 Al 5'Cr-labeled target cells with 150 p1 of a 1 :20 dilution of Hematall LA lysing agent (Fisher Scientific Co., Itasca, IL) and then multiplying the count by two . Maximum release was 100% of the incorporated count . Experimental release was the average of duplicate assays .
Results
High Hepatic NK Cell Activity in MRL/lpr and (NZB X NZW)FI Mice. Hepatic NPC NK cell activity, as measured by cytotoxicity to "Cr-labeled YAC-1 target cells after a 4-h incubation, was always <16% lysis at an E/T ratio of 50:1 in C3H/HeN, BALB/c, DBA/2J, and MRL+/+ female mice at all ages examined and in MRL/lpr female mice <8 wk old . In MRL/lpr mice >8 wk old, cytotoxicity increased from 37% (age 10 wk) to 63% (age 18 wk) (Fig. IA) . In (NZB X NZW)F, mice <3 mo old, NK activity in the younger mice was similar to the nonautoimmune strains; however, the older mice (>3 .5 mo) had higher NK activity ( Fig. 1 B) .
NK Cell Activity: Comparison ofLiver, Spleen, and Peripheral Blood. The markedly high NK cell activity of the liver in MRL/lpr mice was not found in the spleen or peripheral blood mononuclear cells isolated from the same animals ( Fig. 2) . In fact, the splenic NK activity of 4-mo-old MRL/lpr mice was slightly lower than C3H/HeN mice of the same age. However, this latter observation may be secondary to a dilutional effect ; i.e., an increased number of Thy-1', L3T4-, Ly2 -lymphocytes (8) .
Characteristics ofHepatic NK Cells in MRL/lpr Mice. The population of NPC that demonstrated cytotoxicity to YAC-1 targets was found to be resistant to irradiation (Fig. 3A) and not removed by adherence to plastic or carbonyl iron particles (Fig. 3B ). 14-18% of the NPC were AGMI' as determined by FACS analysis. The nonadherent cell population contained <3% macrophages (as measured by phagocytosis of latex beads or positive staining for nonspecific esterase), 25% large granular lymphocytes, and 25-40% large agranular lym- phocytes . In vitro treatment with anti-AGM, and complement eradicated NK activity . Although a mild decrease was noted after treatment with anti-Thy-1 and complement, anti-Lyl and/or anti-Ly2 and complement did not reduce NK activity (Fig . 3 C) .
Hepatic NK Cell Activity : Effect ofBiologic Response Modifiers . A single injection of C. parvum (1 .4 mg i.v. 1-20 d before killed) augmented hepatic and splenic NK activity in nonautoimmune mice (Fig. 4) . Despite high hepatic NK activity in the untreated MRL/lpr mouse, further enhancement was also noted with C. parvum (Fig. 4) . Intraperitoneal injection of poly(I :C) and IFN-a/ß also resulted in increased NK activity in the MRL/lpr and nonautoimmune strains. A similar response to C. parvum was noted in the (NZB x NZW)F, female mice, although less change was noted in the older (6.5-mo-old) mice (data not shown) .
Discussion
This paper provides evidence for extremely high hepatic natural killer cell activity in the autoimmune MRL/lpr and (NZB X NZW)Fi female mice. Although more extreme in the MRL/lpr mice, hepatic NK activity increases with age in both strains and is elevated before the development of autoantibodies or evidence of clinical disease. Moreover, this marked elevation in these autoimmune strains is not reflected in the spleen or peripheral blood. As is the case with the nonautoimmune strains (5), NK activity can be further augmented by in vivo administration of C. parvum, poly(I :C), and IFN-a/ß.
Preliminary characterization of these hepatic NK cells indicates no differences from those isolated from the nonautoimmune strains. They are AGM 1+, Ly-1 -, and Ly-2 -, radioresistant, nonadherent, and not removed by carbonyl iron . The fact that anti-Thy + C' treatment of NPC decreases, but does not eradicate, cytotoxicity to YAC-1 cells suggests that hepatic NK represent a heterogeneous population of cells .
The role that high hepatic NK activity may play in the autoimmune process is conjectural. Our findings may only reflect the sequelae of endogenous Kupffer cell activation of MRL/lpr and (NZB x NZW)F, mice (9) and, therefore, have no functional significance per se. However, activated splenic NK have been shown (4) to regulate T lymphocyte proliferation, as measured by MLR, by eliminating accessory cells that have combined with antigen. Moreover, decreased allogeneic MLR responses, using spleen and lymph node cells from older MRL/lpr mice as stimulators, have been reported (10) . Indeed, we have observed a markedly diminished allogeneic MLR using adherent hepatic NPC from both young and old MRL/lpr mice as stimulators (Magilavy, D. B., and S. L . Latta, manuscript in preparation) .
This finding of high hepatic NK activity in these autoimmune strains appears to conflict with numerous reports of defective or diminished NK activity of peripheral blood from patients with active rheumatoid arthritis or systemic lupus erythematosus (11, 12) . However, the striking compartmental differences in NK activity among the liver, spleen, and peripheral blood of the MRL/lpr mice that we observed may explain the paradox. There are clearly differences among not only the percentage of NK cells in the liver, spleen, and peripheral blood but also the microenvironment of these organs . Because the liver is the major organ responsible for the clearance of soluble IgG immune complexes and foreign antigens, it would not be surprising that hepatic NK from the autoimmune mice are selectively exposed to several secretory products which would result in either activation or recruitment to the liver of NK from other organs .
